DNA Damaging Effects of the Dyes Used in Sentinel Node Biopsy: Possible Implications for Clinical Practice

Journal of Surgical Research

Volumn 154, Issue 2, 2009, Pages 234-238

  Masannat, Yazan Adnan ^a   Hanby, Andrew ^b   Horgan, Kieran ^a   Hardie, Laura J ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

dye; genotoxicity; methylene blue; patent blue V; sentinel node biopsy

Indexed keywords

DISULFINE BLUE; INDIGO CARMINE; METHYLENE BLUE;

ARTICLE; CELL STRAIN MCF 7; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA STRAND BREAKAGE; GENOTOXICITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TOXICITY TESTING;

BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; COLORING AGENTS; DNA DAMAGE; EPITHELIAL CELLS; HUMANS; INDIGOTINDISULFONATE SODIUM; METHYLENE BLUE; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 67349263430     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.039     Document Type: Article

References (24)

1. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599
2. Masannat Y., Shenoy H., Speirs V., et al. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol 32 (2006) 381
3. Simmons R., Thevarajah S., Brennan M.B., et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 10 (2003) 242
4. Nour A. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients. Breast J 10 (2004) 388
5. Blessing W.D., Stolier A.J., Teng S.C., et al. A comparison of methylene blue and lymph azurin in breast cancer sentinel node mapping. Am J Surg 184 (2002) 341
6. Aihara T., and Takatsuka Y. Dye-guided sentinel node biopsy revisited; validation and observational study from a single institute. Breast Cancer 10 (2003) 254
7. Houtgraaf J.H., Versmissen J., and Van der Giessen W.J. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 7 (2006) 165
8. De Bont R., and Van Larebeke N. Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis 19 (2004) 169
9. Olliver J.R., Wild C.P., Sahay P., et al. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 362 (2003) 373
10. Davies J., Burke D., Olliver J.R., et al. Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy. Gut 56 (2007) 55
11. Soule H., Vazguez J., Long A., et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51 (1973) 1409
12. Bartek J., Brartkova J., Kyprianou N., et al. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 88 (1991) 3520
13. Olliver J.R., Hardie L.J., Gong Y., et al. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14 (2005) 620
14. Collins A.R. The comet assay for DNA damage and repair: Principles, applications, and limitations. Molec Biotechnol 26 (2004) 249
15. Gonzalez R., Silva J.M., Dominiguez G., et al. Detection of loss of heterozygosity at Rad51, Rad52, Rad54, and BRCA1 and BRCA2 loci in breast cancer: Pathological correlation. Br J Cancer 81 (1999) 503
16. Smith T.R., Miller S.M., Lohman K.K., et al. DNA damage and breast cancer risk. Carcinogenesis 24 (2003) 883
17. Helzlsouer K.J., Harris E.L., Parshad R., et al. DNA repair proficiency: Potential susceptibility factor for breast cancer. J Natl Cancer Inst 88 (1996) 754
18. Rajeswari N., Ahuja Y.R., Malini U., et al. Risk assessment in first degree female relatives of breast cancer patients using the alkaline comet assay. Carcinogenesis 21 (2000) 557
19. Li D., Wang M., Dhingra K., et al. Aromatic DNA adducts in adjacent tissue of breast cancer patients: Clues to breast cancer etiology. Cancer Res 56 (1996) 287
20. Li D., Zhang W., Zhu J., et al. Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinogen 31 (2001) 214
21. Musarrat J., Arezina-Wilson J., and Wani A.A. Prognostic and etiologic relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 32A (1996) 1209
22. In: Mansel R., and MacNeill F. (Eds). Sentinel lymph node biopsy handbook: New start (2005), The Royal College of Surgeons of England
23. Stradling B., Aranha G., and Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 184 (2002) 350
24. Govaert G.A.M., Oostenbroek R.J., and Plaisier P.W. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 31 (2005) 373